Is ZBH a Buy, Before Earnings?
PremiumPre-EarningsIs ZBH a Buy, Before Earnings?
12d ago
Johnson & Johnson reported strong earnings beat, says Barclays
Premium
The Fly
Johnson & Johnson reported strong earnings beat, says Barclays
25d ago
Zimmer Biomet price target lowered to $135 from $145 at Oppenheimer
Premium
The Fly
Zimmer Biomet price target lowered to $135 from $145 at Oppenheimer
25d ago
Zimmer Biomet management to meet with BTIG
PremiumThe FlyZimmer Biomet management to meet with BTIG
1M ago
Omnicell names Nnamdi Njoku as new COO
Premium
The Fly
Omnicell names Nnamdi Njoku as new COO
1M ago
FDA issues alert for increased risk of fracture after surgery with CPT System
Premium
The Fly
FDA issues alert for increased risk of fracture after surgery with CPT System
2M ago
Wolfe starts Zimmer Biomet at Peer Perform, sees $115-$130 fair value
PremiumThe FlyWolfe starts Zimmer Biomet at Peer Perform, sees $115-$130 fair value
2M ago
Zimmer Biomet initiated with a Peer Perform at Wolfe Research
Premium
The Fly
Zimmer Biomet initiated with a Peer Perform at Wolfe Research
2M ago
Zimmer Biomet guidance update an ‘unwelcome negative,’ says Truist
Premium
The Fly
Zimmer Biomet guidance update an ‘unwelcome negative,’ says Truist
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100